PURETECH Financial Statements From 2010 to 2025
| 0VQ Stock | EUR 1.65 0.09 5.17% |
Check PURETECH HEALTH financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among PURETECH HEALTH's main balance sheet or income statement drivers, such as , as well as many indicators such as . PURETECH financial statements analysis is a perfect complement when working with PURETECH HEALTH Valuation or Volatility modules.
PURETECH |
PURETECH HEALTH PLC Company Shares Owned By Insiders Analysis
PURETECH HEALTH's Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current PURETECH HEALTH Shares Owned By Insiders | 15.48 % |
Most of PURETECH HEALTH's fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PURETECH HEALTH PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 15.482% of PURETECH HEALTH PLC are shares owned by insiders. This is much higher than that of the sector and significantly higher than that of the Shares Owned By Insiders industry. The shares owned by insiders for all Germany stocks is notably lower than that of the firm.
PURETECH HEALTH PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining PURETECH HEALTH's current stock value. Our valuation model uses many indicators to compare PURETECH HEALTH value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across PURETECH HEALTH competition to find correlations between indicators driving PURETECH HEALTH's intrinsic value. More Info.PURETECH HEALTH PLC is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PURETECH HEALTH's earnings, one of the primary drivers of an investment's value.About PURETECH HEALTH Financial Statements
PURETECH HEALTH stakeholders use historical fundamental indicators, such as PURETECH HEALTH's revenue or net income, to determine how well the company is positioned to perform in the future. Although PURETECH HEALTH investors may analyze each financial statement separately, they are all interrelated. For example, changes in PURETECH HEALTH's assets and liabilities are reflected in the revenues and expenses on PURETECH HEALTH's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in PURETECH HEALTH PLC. Please read more on our technical analysis and fundamental analysis pages.
PureTech Health plc, a clinical stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PURETECH HEALTH is traded on Frankfurt Stock Exchange in Germany.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in PURETECH Stock
When determining whether PURETECH HEALTH PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PURETECH HEALTH's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:Check out the analysis of PURETECH HEALTH Correlation against competitors. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..